Patient selection for neoadjuvant chemotherapy trials

International Journal of Gynecological Cancer

Volumn 13, Issue 6, 2003, Pages 912-913

  Narayan, K ^a   Quinn, M A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; NAVELBINE;

BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL RESEARCH; CLINICAL TRIAL; FEMALE; GYNECOLOGIC CANCER; HUMAN; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS, PHASE III; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOADJUVANT THERAPY; NEOPLASM STAGING; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 1242339587     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2003.13625.x     Document Type: Letter

References (3)

1. Di Vagno G, Cormio G, Pignata S et al. Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: A Phase II study. Int J Gynecol Cancer 2003;13:308-12.
2. Landoni F, Maneo A, Colombo A et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer [see comments]. Lancet 1997;350:535-40.
3. Narayan K, McKenzie AF, Hicks RJ, Fisher R, Bernshaw D, Bau S. Relation between FIGO stage, primary tumor volume and presence of lymph node metastases in cervical cancer patients referred for radiotherapy. Int J Gynecol Cancer in press.